Search

everythinglearnresearchcommunity

for

Search:↓

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

Targeting specific molecular pathways may improve treatments for chemoresistant cancers.

Dutasteride may protect brain cells in early Parkinson's, while progesterone helps neuron recovery.

New compounds may help treat prostate issues without affecting androgen receptors.

Finasteride may improve stem cell therapy for heart attacks by increasing cell survival.

"Flosin – Prostamol Uno" effectively manages BPH symptoms with fewer side effects.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Best treatment for Frontal Fibrosing Alopecia is 5-alpha-reductase inhibitors and intralesional corticosteroids.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

D-004 shows moderate antidepressant effects but is less effective than Sertraline and Imipramine.

DA-9401 can protect against finasteride-induced reproductive damage in rats.

Finasteride reduces sperm count and affects male reproductive function, while Epristeride does not.

Resistance exercise can reduce muscle protein issues caused by finasteride.

Finasteride harms Daphnia magna's reproduction, growth, and metabolism.

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.

Finasteride effectively reduces DHT and E2 levels, helping with prostate enlargement.

Early diagnosis and treatment can prevent or delay frontal fibrosing alopecia progression in postmenopausal women.

Alpha-tocopherol does not prevent hair loss from doxorubicin.